Kimberly M. Murphy
Known title: CEO and PresidentCIK: 0001810474
Associated companies
Transaction History
| OGEN | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 | View on chart |
| OGEN | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Oragenics (OGEN) noted in after‑market health‑care stock activity
OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.
Oragenics (OGEN) noted in after‑market health‑care stock activity. OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.